Abra Bound 100mg Injection (Albumin Bound Paclitaxel)

Abra Bound 100mg Injection is a prescription-based anticancer medicine used in the treatment of breast cancer, pancreatic cancer, and non-small cell lung cancer. The active ingredient of the Abra Bound is Paclitaxel Protein-Bound, which belongs to the drug class of the Taxane family. Its mode of action involves the disruption of the microtubules responsible for division and multiplication of the cancerous cells, thus killing them. Paclitaxel protein-bound injection is usually given in combination with another anticancer medicine as a part of combination therapy to increase the efficacy of the treatment.

The injection is administered as an intravenous infusion by a qualified doctor in a hospital or clinical setting. The doctor determines the dosage of the Paclitaxel Protein-Bound 100mg injection according to the type of cancer, treatment regimen, age, and overall health of the patient. It should not be self-administered. Patients are advised not to change the dosage and timings prescribed by the doctors because it can cause severe side effects.

Common side effects include tiredness, weakness, nausea, vomiting, diarrhea, decreased appetite, hair loss, muscle or joint pain, and changes in blood cell counts. A few patients can undergo severe side effects, including difficulty in breathing, severe allergic symptoms, persistent fever and unusual bleeding. Most of the paclitaxel protein-bound 100mg injection side effects can leave when the body adapts to the medicine. However, report to your doctor if you experience serious side effects.

The medicine may cause harm to an unborn baby, so pregnancy should be avoided, and breastfeeding must be consulted with a doctor. Patients must list all medicines, supplements, and herbal products that they are taking. The Paclitaxel Protein-Bound 100mg injection must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.

Breast Cancer

The human body shows undesired symptoms after taking Abra Bound 100mg Injection (Paclitaxel Protein Bound). Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.

Paclitaxel Protein Bound 100mg Injection (Abra Bound) is a prescription-based anticancer drug. It is advised to take this injection after consulting your healthcare expert. This medicine should be given intravenously by an experienced nurse or doctor. Please do not self-administer.

● Saif, M. W. (2013). US Food and Drug Administration approves paclitaxel protein-bound particles (Abraxane®) in combination with gemcitabine as first-line treatment of patients with metastatic pancreatic cancer. JOP. Journal of the Pancreas, 14(6), 686-688.
● Di Costanzo, F., Gasperoni, S., Rotella, V., & Di Costanzo, F. (2009). Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer. OncoTargets and therapy, 179-188.
● Yardley, D. A. (2013). nab-Paclitaxel mechanisms of action and delivery. Journal of Controlled Release, 170(3), 365-372.
● Gupta, N., Hatoum, H., & Dy, G. K. (2014). First line treatment of advanced non-small-cell lung cancer–specific focus on albumin bound paclitaxel. International journal of nanomedicine, 209-221.
● Stinchcombe, T. E. (2007). Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL®-free formulation of paclitaxel. Nanomedicine, 2(4), 415-423.
● Blair, H. A., & Deeks, E. D. (2015). Albumin-bound paclitaxel: a review in non-small cell lung cancer. Drugs, 75(17), 2017-2024.